Large Molecule Research & Perspectives

  1. Achieving 3-4-Fold Higher Titers Of Monoclonal Antibodies 5/26/2026

    An intensified fed-batch process boosts monoclonal antibody production 3–4× by optimizing cell density, improving efficiency, lowering costs, and maintaining consistent quality.

  2. Cell Line Development: Faster Path To A Stable Master Cell Bank 5/26/2026

    Cell line development builds stable, high-yield cell lines and a master cell bank, enabling consistent, scalable biologics manufacturing through selection, characterization, and cryopreservation.

  3. How Antibody Drug Conjugate Therapies Deliver Precision 5/26/2026

    Antibody drug conjugates target cancer cells with potent payloads, combining precision and cytotoxicity to boost efficacy, reduce toxicity, and tackle complex tumors.

  4. Untapped Potential In Animal Health Innovation 5/26/2026

    Animal health innovation is driving rapid market growth, fueled by rising demand and complexity, creating opportunities for advanced therapies, sustainability, and better disease management.

  5. A Platform That's Revolutionizing Biopharma Manufacturing 5/26/2026

    Integrated platform boosts biologics manufacturing by raising protein yield, speeding timelines, and improving scalability via cell line development, process optimization, and data-driven design.

  6. Why Strategic Outsourcing In Biologics Is No Longer Optional 5/26/2026
  7. Antibody Drug Conjugates Re-Emergence Of An Old Modality 5/26/2026

    Antibody-drug conjugates link targeted antibodies with potent drugs to treat cancer more precisely, though challenges remain in stability, conjugation, and scalable production.